UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 156

Sortiert nach

The landscape and therapeutic relevance of cancer-associated transcript fusions

Oncogene, 2015-09, Vol.34 (37), p.4845-4854

2015

Volltextzugriff (PDF)

Evolutionary dynamics of residual disease in human glioblastoma

Annals of oncology, 2019-03, Vol.30 (3), p.456-463

2019

Volltextzugriff (PDF)

Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling

Haematologica (Roma), 2009-01, Vol.94 (1), p.131-134

2009

Volltextzugriff (PDF)

New hints towards a precision medicine strategy for IDH wild-type glioblastoma

Annals of oncology, 2020-12, Vol.31 (12), p.1679-1692

2020

Volltextzugriff (PDF)

HIGH-THROUGHPUT SCREENING OF GLIOMA STEM CELL LINES FOR DRUG STRUCTURE- AND GENOTYPE-CORRELATED SENSITIVITY TO A PANEL OF TYROSINE KINASE INHIBITORS

Neuro-oncology (Charlottesville, Va.), 2014-07, Vol.16 (suppl 3), p.iii32-iii32

2014

Volltextzugriff (PDF)

PO-390 Image-guided stereotactic molecular profiling of samples taken in- and outside conventional tumour boundaries highlight extensive infiltration of tumour cells in diffuse gliomas

ESMO open, 2018-07, Vol.3 (Suppl 2), p.A175-A175

2018

Volltextzugriff (PDF)

340O Radiotherapy is associated with deletion signatures that contribute to poor survival outcomes in cancer patients

Annals of oncology, 2021-09, Vol.32, p.S516-S516

2021

Volltextzugriff (PDF)

JS08.7.A Integrative analysis of longitudinal genomic and non-genetic mechanisms of radiotherapy-resistance in glioma

Neuro-oncology (Charlottesville, Va.), 2022-09, Vol.24 (Supplement_2), p.ii9-ii9

2022

Volltextzugriff (PDF)

Integrated genomic analyses of ovarian carcinoma

Nature (London), 2011-06, Vol.474 (7353), p.609-615

2011

Volltextzugriff (PDF)

JS04.5.A HEMIZYGOUS CDKN2A DELETION CONFERS WORSE SURVIVAL OUTCOMES IN IDH-MUTANT GLIOMAS

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii8-ii8

2023

Volltextzugriff (PDF)

PL03.2.A Radiotherapy is associated with a deletion signature that contributes to poor outcomes in glioma patients

Neuro-oncology (Charlottesville, Va.), 2021-09, Vol.23 (Supplement_2), p.ii2-ii2

2021

Volltextzugriff (PDF)

GE-37 INTEGRATED GENOMIC ANALYSIS OF LOW GRADE GLIOMA AND GLIOBLASTOMA REVEALS MOLECULAR STRATIFICATION BY IDH STATUS ACROSS GRADES AND HISTOLOGIES

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v104-v104

2014

Volltextzugriff (PDF)

JS09.7.A COMBINATION OF APPARENT DIFFUSION COEFFICIENT AND FET PET COMPARED WITH STANDARD IMAGING FOR QUANTITATIVE TUMOR PRESENCE IN DIFFUSE GLIOMAS

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii13-ii13

2023

Volltextzugriff (PDF)

PDPN+ Tumor Initiating, Treatment Resistant Glioblastoma Cells Promote Radiation Resistance Via PRC2

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e510-e510

2020

Volltextzugriff (PDF)

Abstract GS1-05: Tandem duplicator phenotypes define 50% of triple negative breast cancers

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.GS1-05-GS1-05

2018

Volltextzugriff (PDF)

Comprehensive molecular portraits of human breast tumours

Nature (London), 2012-10, Vol.490 (7418), p.61-70

Prat Aparicio, Aleix

2012

Volltextzugriff (PDF)

P01.035 Nivolumab and Temozolomide (TMZ) vs TMZ alone in newly diagnosed elderly patients (pts) with Glioblastoma (GBM) (NUTMEG): Trial in progress

Neuro-oncology (Charlottesville, Va.), 2018-09, Vol.20 (suppl_3), p.iii236-iii236

2018

Volltextzugriff (PDF)

DR-08 MSK1/ -CATENIN SIGNALING MEDIATES RESISTANCE TO PI3K/mTOR INHIBITORS IN GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v64-v64

2014

Volltextzugriff (PDF)

GE-41 COMPREHENSIVE AND INTEGRATIVE GENOMIC CHARACTERIZATION OF DIFFUSE LOWER GRADE GLIOMAS

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v105-v105

2014

Volltextzugriff (PDF)

GE-39 VALIDATION OF GLIOMA SPHERE-FORMING CELLS AS MODELS OF GLIOBLASTOMA AND IDENTIFICATION OF NOVEL DRIVERS OF TUMORIGENESIS THROUGH COMPREHENSIVE GENOMIC CHARACTERIZATION

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v105-v105

2014

Volltextzugriff (PDF)

GE-38 IDENTIFYING THE TREATMENT-RESISTANT MESENCHYMAL SIGNATURE BY COMPARATIVE ANALYSES BETWEEN GLIOMA SPHERE-FORMING CELLS AND THEIR GLIOBLASTOMAS OF ORIGIN

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v104-v105

2014

Volltextzugriff (PDF)

SC-01 HnRNPA1 PROTEIN DEREGULATES Baf45d mRNA SPLICING IN GLIOMA: FUNCTION AND MECHANISM

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v197-v197

2014

Volltextzugriff (PDF)

GE-14 TRANSCRIPTOMICPLASTICITYIS ASSOCIATED WITH THE TUMOR MICROENVIRONMENT IN GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v99-v99

2014

Volltextzugriff (PDF)

THE P53 PATHWAY AND ANCESTRAL PROGENITORS ARE ASSOCIATED WITH TUMOR RECURRENCE IN GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2014-07, Vol.16 (suppl 3), p.iii3-iii3

2014

Volltextzugriff (PDF)

1 – 25 von 156

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(117)

Publikationsform

Artikel
(141)
Reviews
(13)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neuro-Oncology
(21)
Bijdragen Tijdschrift Voor Filosofie En Theologie
(15)
Bijdragen
(14)
Cancer Cell
(7)
Cell
(6)
Human Reproduction
(5)
Nature
(5)
Annals Of Oncology
(4)
Cancer Research
(4)
Nature Genetics
(4)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The landscape and therapeutic relevance of cancer-associated transcript fusions

Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy

Evolutionary dynamics of residual disease in human glioblastoma

Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling

New hints towards a precision medicine strategy for IDH wild-type glioblastoma

HIGH-THROUGHPUT SCREENING OF GLIOMA STEM CELL LINES FOR DRUG STRUCTURE- AND GENOTYPE-CORRELATED SENSITIVITY TO A PANEL OF TYROSINE KINASE INHIBITORS

PO-390 Image-guided stereotactic molecular profiling of samples taken in- and outside conventional tumour boundaries highlight extensive infiltration of tumour cells in diffuse gliomas

340O Radiotherapy is associated with deletion signatures that contribute to poor survival outcomes in cancer patients

JS08.7.A Integrative analysis of longitudinal genomic and non-genetic mechanisms of radiotherapy-resistance in glioma

Integrated genomic analyses of ovarian carcinoma

JS04.5.A HEMIZYGOUS CDKN2A DELETION CONFERS WORSE SURVIVAL OUTCOMES IN IDH-MUTANT GLIOMAS

PL03.2.A Radiotherapy is associated with a deletion signature that contributes to poor outcomes in glioma patients

GE-37 INTEGRATED GENOMIC ANALYSIS OF LOW GRADE GLIOMA AND GLIOBLASTOMA REVEALS MOLECULAR STRATIFICATION BY IDH STATUS ACROSS GRADES AND HISTOLOGIES

JS09.7.A COMBINATION OF APPARENT DIFFUSION COEFFICIENT AND FET PET COMPARED WITH STANDARD IMAGING FOR QUANTITATIVE TUMOR PRESENCE IN DIFFUSE GLIOMAS

PDPN+ Tumor Initiating, Treatment Resistant Glioblastoma Cells Promote Radiation Resistance Via PRC2

Abstract GS1-05: Tandem duplicator phenotypes define 50% of triple negative breast cancers

Comprehensive molecular portraits of human breast tumours

P01.035 Nivolumab and Temozolomide (TMZ) vs TMZ alone in newly diagnosed elderly patients (pts) with Glioblastoma (GBM) (NUTMEG): Trial in progress

DR-08 MSK1/ -CATENIN SIGNALING MEDIATES RESISTANCE TO PI3K/mTOR INHIBITORS IN GLIOBLASTOMA

GE-41 COMPREHENSIVE AND INTEGRATIVE GENOMIC CHARACTERIZATION OF DIFFUSE LOWER GRADE GLIOMAS

GE-39 VALIDATION OF GLIOMA SPHERE-FORMING CELLS AS MODELS OF GLIOBLASTOMA AND IDENTIFICATION OF NOVEL DRIVERS OF TUMORIGENESIS THROUGH COMPREHENSIVE GENOMIC CHARACTERIZATION

GE-38 IDENTIFYING THE TREATMENT-RESISTANT MESENCHYMAL SIGNATURE BY COMPARATIVE ANALYSES BETWEEN GLIOMA SPHERE-FORMING CELLS AND THEIR GLIOBLASTOMAS OF ORIGIN

SC-01 HnRNPA1 PROTEIN DEREGULATES Baf45d mRNA SPLICING IN GLIOMA: FUNCTION AND MECHANISM

GE-14 TRANSCRIPTOMICPLASTICITYIS ASSOCIATED WITH THE TUMOR MICROENVIRONMENT IN GLIOBLASTOMA

THE P53 PATHWAY AND ANCESTRAL PROGENITORS ARE ASSOCIATED WITH TUMOR RECURRENCE IN GLIOBLASTOMA

Suchergebnisse filtern